University of Michigan
Ann Arbor, Michigan, United States
My research program focuses on elucidating the epigenetic contribution to the pathogenesis of autoimmune diseases, with a specific focus on the vascular complications in systemic sclerosis (scleroderma, SSc). By applying unbiased-epigenomics and bioinformatics methodologies, followed by functional studies to identify relevant pathways and targets pertinent to the disease, my ultimate goal is to identify epigenetic markers that define SSc pathogenesis and progression, patient heterogeneity, and response to therapy.
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
Senescence and the Scleroderma Vasculature: A New Lens on Disease Mechanisms
Sunday, October 26, 2025
4:00 PM - 4:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
0972: Prominent endothelial senescence in systemic sclerosis skin
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
1871: Examining the Impact of ETV2 on altered endothelial phenotype in systemic sclerosis
Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
